written on 17.04.2014

England sets aside $31M to fund Sovaldi for sickest patients


While next-gen hep C treatment Sovaldi costs $84,000 per 12-week course of treatment, it boasts a 90% cure rate–and that's convinced the U.K.'s National Health Service to spend £18.7 million to fund the treatment for England's sickest patients.

Latest Reports